Ultragenyx Pharmaceutical Inc.

RARE

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001515673

SEC filings (opens in a new tab)

In the last 90 days, Ultragenyx Pharmaceutical Inc. insiders filed 0 open-market purchases and 4 sales; 311 institutions reported holding it in 13F filings for Q2 2026, worth $3.55B in total; no superinvestor holds it.

Q4 2023 vs. Q3 2023

How the institutions holding Ultragenyx Pharmaceutical Inc. changed between Q3 2023 and Q4 2023.

All holders in Q4 2023 All holders in Q3 2023

13F holders of RARE: Q3 2023 compared with Q4 2023
Measure	Q3 2023	Of which not filed for Q4 2023	Q4 2023	Change
Holders	221	4	237	+20
Shares	70.6M	481.1K	80.4M	+10.3M (+14.7%)
Value	$2.52B	$17.1M	$3.84B	+$1.34B (+53.8%)

4 institutions that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so the changes leave them out.

New holders (43)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q4 2023 but not at the end of Q3 2023.

Institutions new to RARE in Q4 2023
Institution	Shares	Value	% of portfolio
Camber Capital Management LP	900,000	$43.0M	1.50%
Schonfeld Strategic Advisors LLC	342,812	$16.4M	0.13%
Blue Owl Capital Holdings LP	263,238	$12.6M	3.01%
Schroder Investment Management Group	250,052	$12.0M	0.02%
AQR Capital Management LLC	170,689	$8.16M	0.02%
Standard Life Aberdeen plc	141,117	$6.75M	0.01%
Cinctive Capital Management LP	98,051	$4.69M	0.33%
Balyasny Asset Management LLC	82,933	$3.97M	0.01%
BNP PARIBAS ASSET MANAGEMENT Holding S.A.	82,619	$3.95M	0.01%
NFJ Investment Group, LLC	44,084	$2.11M	0.06%
Susquehanna Portfolio Strategies, LLC	24,147	$1.15M	0.02%
HRT Financial LP	18,299	$875.0K	0.01%
Squarepoint Ops LLC	15,841	$757.5K	0.00%
Graham Capital Management, L.P.	13,860	$662.8K	0.02%
NEOS Investment Management LLC	10,797	$516.3K	0.05%
Ghisallo Capital Management LLC	10,000	$478.2K	0.05%
Camden Capital, LLC	9,145	$437.3K	0.04%
Pitcairn Co	8,636	$413.0K	0.03%
Woodstock Corp	8,060	$385.4K	0.04%
Gotham Asset Management, LLC	7,478	$357.6K	0.01%
Verition Fund Management LLC	7,070	$338.1K	0.00%
M&T Bank Corp	6,486	$310.2K	0.00%
Wealth Enhancement Advisory Services, LLC	6,176	$295.3K	0.00%
Maryland State Retirement & Pension System	6,111	$292.2K	0.01%
ProShare Advisors LLC	5,588	$267.2K	0.00%
EFG Asset Management (Americas) Corp.	5,274	$252.2K	0.05%
Cornercap Investment Counsel Inc	5,146	$246.1K	0.04%
Prelude Capital Management, LLC	4,900	$234.3K	0.02%
Vident Advisory, LLC	4,487	$214.6K	0.01%
Angeles Investment Advisors, LLC	4,447	$212.7K	0.01%
Utah Retirement Systems	4,300	$205.6K	0.00%
Mirabella Financial Services LLP	4,280	$204.7K	0.03%
BIT Capital GmbH	1,555	$74.4K	0.01%
Ci Investments Inc.	1,255	$60.0K	0.00%
West Tower Group, LLC	402	$19.2K	0.04%
BFSG, LLC	200	$9.56K	0.00%
GAMMA Investing LLC	139	$6.13K	0.00%
Private Wealth Management Group, LLC	34	$1.63K	0.00%
Sachetta, LLC	32	$1.53K	0.00%
JJJ Advisors Inc.	20	$957	0.00%
Signature Resources Capital Management, LLC	15	$717	0.00%
Advisory Services Network, LLC	1	$48	0.00%
Farther Finance Advisors, LLC	1	$48	0.00%

Sold out (23)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q3 2023 and filed for Q4 2023 without it.

Institutions that sold out of RARE in Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
Ikarian Capital, LLC	174,945	$6.24M
Bank of Nova Scotia	42,451	$1.51M
Boothbay Fund Management, LLC	37,591	$1.34M
Natixis	33,100	$1.18M
AlphaCentric Advisors LLC	30,000	$1.07M
Cubist Systematic Strategies, LLC	29,178	$1.04M
Jump Financial, LLC	23,436	$835.5K
Y-Intercept (Hong Kong) Ltd	15,442	$550.5K
HighVista Strategies LLC	14,591	$520.2K
Aquatic Capital Management LLC	12,800	$456.0K
DnB Asset Management AS	12,674	$451.8K
Corton Capital Inc.	8,856	$315.7K
Point72 Middle East FZE	7,243	$258.2K
Aigen Investment Management, LP	6,732	$240.0K
Prudential Financial Inc	6,409	$228.5K
D. E. Shaw & Co., Inc.	6,152	$219.3K
Headlands Technologies LLC	3,351	$119.5K
Essex Investment Management Co LLC	1,481	$52.8K
Cutler Group LP	1,010	$36.0K
Clear Street Markets LLC	657	$23.0K
Loomis Sayles & Co L P	152	$5.00K
IFP Advisors, Inc	73	$2.60K
Crewe Advisors LLC	3	$107

Not filed for Q4 2023 yet (4)

Institutions that held Ultragenyx Pharmaceutical Inc. at the end of Q3 2023 and haven't filed a 13F for Q4 2023. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding RARE in Q3 2023 that haven't filed for Q4 2023
Institution	Shares, Q3 2023	Value, Q3 2023
International Biotechnology Trust PLC	250,052	$8.91M
CHI Advisors LLC	215,000	$7.66M
Virginia Retirement Systems Et Al	14,300	$509.8K
Column Capital Advisors, LLC	1,704	$60.7K